CXCR4 and neoplasm: After having visualized CXCR4 expression of tumor lesions in an in vivo setting, patients can be scheduled for CXCR4-directed ERT using the ß-emitting theranostic twin [177Lu]/[90Y]PentixaTher (Fig. 1).